The corticosteroid equivalence converter translates a dose of one glucocorticoid into the equivalent dose of another, based on their relative anti-inflammatory potency. It is the everyday tool for switching steroids, planning a taper, or converting an IV regimen to oral.
How it works
Every glucocorticoid is anchored to hydrocortisone (cortisol). The table
lists the dose of each drug that equals 20 mg of hydrocortisone in
anti-inflammatory effect:
| Steroid | Equivalent dose (anti-inflammatory) |
|---|---|
| Hydrocortisone | 20 mg |
| Cortisone acetate | 25 mg |
| Prednisone | 5 mg |
| Prednisolone | 5 mg |
| Methylprednisolone | 4 mg |
| Triamcinolone | 4 mg |
| Deflazacort | 7.5 mg |
| Dexamethasone | 0.75 mg |
| Betamethasone | 0.6 mg |
To convert, the tool applies:
Target dose = source dose × (target equivalent ÷ source equivalent)
For example: 40 mg prednisolone × (0.75 ÷ 5) = 6 mg dexamethasone.
Worked conversion example
A patient on 30 mg prednisolone daily needs to switch to dexamethasone:
Source: prednisolone, equivalent dose = 5 mg
Target: dexamethasone, equivalent dose = 0.75 mg
Conversion ratio = 0.75 / 5 = 0.15
Dexamethasone dose = 30 mg × 0.15 = 4.5 mg
This means 4.5 mg dexamethasone provides roughly the same anti-inflammatory effect as 30 mg prednisolone. In practice, dexamethasone’s much longer half-life means dosing frequency also changes.
Three properties the table does NOT match
Understanding what this conversion does not cover is as important as the numbers themselves.
1. Mineralocorticoid (salt-retaining) effect
Hydrocortisone and cortisone have substantial aldosterone-like activity, causing sodium and water retention. Prednisolone has mild mineralocorticoid activity. Dexamethasone and betamethasone have almost none. This distinction is clinically critical in adrenal insufficiency, where physiological replacement requires covering both glucocorticoid and mineralocorticoid needs. Switching from hydrocortisone to dexamethasone for adrenal replacement using only this equivalence table would leave the patient without mineralocorticoid coverage.
2. Duration of action and dosing frequency
Short-acting steroids (hydrocortisone: 8–12 hours) are given two or three times daily; intermediate-acting agents (prednisolone: 12–36 hours) once daily; long-acting agents (dexamethasone: 36–54 hours) once daily or every other day. An equivalent anti-inflammatory dose does not mean the same dosing schedule.
3. HPA-axis suppression
Long-acting agents such as dexamethasone suppress the hypothalamic-pituitary-adrenal axis more continuously than short-acting agents at equivalent doses. This matters when planning a steroid taper or when assessing surgical stress coverage.
Budesonide and inhaled steroids
Budesonide undergoes extensive first-pass hepatic metabolism when absorbed systemically, so there is no reliable single number for systemic equivalence. It is intentionally excluded from this converter. Inhaled corticosteroids (ICS) similarly have published topical potency rankings that do not translate into meaningful systemic equivalence figures for anti-inflammatory dosing.
Safe use note
Never stop chronic corticosteroids abruptly — even a short course can suppress the HPA axis enough to require a gradual taper. This tool assists with dose calculations for educational and planning purposes; all dose decisions should be confirmed by a prescribing clinician. All calculation runs locally in your browser with nothing uploaded.